EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy

Natália Noronha Ferreira, Renata Rank Miranda, Natália Sanchez Moreno, Paula Maria Pincela Lins, Celisnolia Morais Leite, Ana Elisa Tognoli Leite, Thales Rafael Machado, Thaís Regiani Cataldi, Carlos Alberto Labate, Rui Manuel Reis, Valtencir Zucolotto

Frontiers in Bioengineering and Biotechnology · 02.02.2023 · 11

DOI: 10.3389/fbioe.2023.1120179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 02.02.2023. Verfasst von Natália Noronha Ferreira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, São Carlos, Brazil. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cell membrane-covered biomimetic nanosystems have allowed the development of homologous nanostructures to bestow nanoparticles with enhanced biointerfacing capabilities. The stability of these structures, however, still represents a challenge for the scientific community. This study is aimed at developing and optimizing cell derived membrane-coated nanostructures upon applying design of experiments (DoE) to improve the therapeutic index by homotypic targeting in cancer cells.

Methods

Important physicochemical features of the extracted cell membrane from tumoral cells were assessed by mass spectrometry-based proteomics. PLGA-based nanoparticles encapsulating temozolomide (TMZ NPs) were successfully developed. The coating technology applying the isolated U251 cell membrane (MB) was optimized using a fractional two-level three-factor factorial design. All the formulation runs were systematically characterized regarding their diameter, polydispersity index (PDI), and zeta potential (ZP). Experimental conditions generated by DoE were also subjected to morphological studies using negative-staining transmission electron microscopy (TEM). Its short-time stability was also assessed. MicroRaman and Fourier-Transform Infrared (FTIR) spectroscopies and Confocal microscopy were used as characterization techniques for evaluating the NP-MB nanostructures. Internalization studies were carried out to evaluate the homotypic targeting ability. Results and Discussion: The results have shown that nearly 80% of plasma membrane proteins were retained in the cell membrane vesicles after the isolation process, including key proteins to the homotypic binding. DoE analysis considering acquired TEM images reveals that condition run five should be the best-optimized procedure to produce the biomimetic cell-derived membrane-coated nanostructure (NP-MB). Storage stability for at least two weeks of the biomimetic system is expected once the original characteristics of diameter, PDI, and ZP, were maintained. Raman, FTIR, and confocal characterization results have shown the successful encapsulation of TMZ drug and provided evidence of the effective coating applying the MB. Cell internalization studies corroborate the proteomic data indicating that the optimized NP-MB achieved specific targeting of homotypic tumor cells. The structure should retain the complex biological functions of U251 natural cell membranes while exhibiting physicochemical properties suitable for effective homotypic recognition.

Conclusion

Together, these findings provide coverage and a deeper understanding regarding the dynamics around extracted cell membrane and polymeric nanostructures interactions and an in-depth insight into the cell membrane coating technology and the development of optimized biomimetic and bioinspired nanostructured systems.

Schlagwörter

Stichwörter der Autor:innen

biomimetic systemscell membrane coating technologydesign of experiment-DoEglioblastomahomotypic recognitionmass spectrometry-based proteomicsstabilitytemozolomide drug

Autor:innen und Institutionen

  • Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, São Carlos, Brazil.
  • Max Feffer Laboratory of Plant Genetics, Department of Genetics, ESALQ, University of São Paulo, Piracicaba, Brazil.
  • Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Ferreira, N. N., Miranda, R. R., Moreno, N. S., Pincela Lins, P. M., Leite, C. M., Leite, A. E. T., Machado, T. R., Cataldi, T. R., Labate, C. A., Reis, R. M., & Zucolotto, V. (2023). Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1120179

Vancouver

Ferreira NN, Miranda RR, Moreno NS, Pincela Lins PM, Leite CM, Leite AET, et al. Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1120179

BibTeX
@article{Ferreira2023,
  author = {Ferreira, Natália Noronha and Miranda, Renata Rank and Moreno, Natália Sanchez and Pincela Lins, Paula Maria and Leite, Celisnolia Morais and Leite, Ana Elisa Tognoli and Machado, Thales Rafael and Cataldi, Thaís Regiani and Labate, Carlos Alberto and Reis, Rui Manuel and Zucolotto, Valtencir},
  title = {Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fbioe.2023.1120179}
}
Kostenlos starten →